Assertio Holdings Inc (ASRT)
1.03
+0.02
(+1.98%)
USD |
NASDAQ |
May 03, 16:00
1.025
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Accounts Receivable (Quarterly): 47.66M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 47.66M |
September 30, 2023 | 62.47M |
June 30, 2023 | 41.61M |
March 31, 2023 | 46.47M |
December 31, 2022 | 45.36M |
September 30, 2022 | 42.06M |
June 30, 2022 | 46.56M |
March 31, 2022 | 48.92M |
December 31, 2021 | 44.36M |
September 30, 2021 | 36.14M |
June 30, 2021 | 45.37M |
March 31, 2021 | 38.92M |
December 31, 2020 | 44.35M |
September 30, 2020 | 38.50M |
June 30, 2020 | 34.65M |
March 31, 2020 | 12.43M |
December 31, 2019 | 42.46M |
September 30, 2019 | 43.15M |
June 30, 2019 | 34.19M |
March 31, 2019 | 43.37M |
December 31, 2018 | 37.09M |
September 30, 2018 | 30.48M |
June 30, 2018 | 24.61M |
March 31, 2018 | 62.09M |
December 31, 2017 | 71.92M |
Date | Value |
---|---|
September 30, 2017 | 77.19M |
June 30, 2017 | 78.34M |
March 31, 2017 | 67.52M |
December 31, 2016 | 102.06M |
September 30, 2016 | 86.96M |
June 30, 2016 | 79.48M |
March 31, 2016 | 69.90M |
December 31, 2015 | 71.12M |
September 30, 2015 | 68.36M |
June 30, 2015 | 59.75M |
March 31, 2015 | 23.45M |
December 31, 2014 | 27.01M |
September 30, 2014 | 19.95M |
June 30, 2014 | 17.27M |
March 31, 2014 | 12.75M |
December 31, 2013 | 11.45M |
September 30, 2013 | 8.312M |
June 30, 2013 | 6.717M |
March 31, 2013 | 5.292M |
December 31, 2012 | 3.614M |
September 30, 2012 | 4.848M |
June 30, 2012 | 1.945M |
March 31, 2012 | 0.486M |
December 31, 2011 | 4.42M |
September 30, 2011 | 0.827M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
12.43M
Minimum
Mar 2020
62.47M
Maximum
Sep 2023
41.88M
Average
43.15M
Median
Sep 2019
Accounts Receivable (Quarterly) Benchmarks
Ocular Therapeutix Inc | 26.18M |
Cormedix Inc | -- |
Verastem Inc | 0.00 |
Puma Biotechnology Inc | 47.84M |
CytomX Therapeutics Inc | 3.432M |